ABCG1 and metabolic syndrome: After dividing patients of Group M in those with and without MetS, a significant steady decrease in the ABCG1-mediated CEC was found from controls to Group G and from Group M/MetS− to Group M/MetS+ patients (p for trend = 0.031, Figure 2, Panel B).